Novo-Nordisk A/S Share Price
NYSE: NVONovo-Nordisk A/S Stock Performance
Novo-Nordisk A/S Share Price Today
As of 1 November 2026, Novo-Nordisk A/S's share price is $39.97. The stock opened at $39.63, compared to its previous close of $39.20. During today's trading session, Novo-Nordisk A/S's share price traded between $39.55 and $40.09, with an average price of $39.82. Over the past 52 weeks, the stock has recorded a high of $64.16 and a low of $35.13. In terms of performance, Novo-Nordisk A/S's share price has declined by 5.27% over the last six months and is down 19.15% on a year-on-year basis.
Novo-Nordisk A/S Share Price Chart
About Novo-Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Novo-Nordisk A/S Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $37.76 | $39.95 | +5.35% |
Sep 2026 | $45.81 | $37.92 | -18.02% |
Aug 2026 | $47.04 | $46.26 | -1.74% |
Jul 2026 | $49.04 | $47.08 | -1.80% |
Jun 2026 | $45.39 | $47.95 | +5.14% |
May 2026 | $43.32 | $45.60 | +8.07% |
Apr 2026 | $36.80 | $42.20 | +14.85% |
Mar 2026 | $36.73 | $36.74 | -1.92% |
Feb 2026 | $57.91 | $37.46 | -36.98% |
Jan 2026 | $51.64 | $59.44 | +16.82% |
Dec 2025 | $48.92 | $50.88 | +3.18% |
Nov 2025 | $49.41 | $49.31 | -0.26% |